5.3 Adrenal Crisis & Thyroid Emergencies

Introduction to Adrenal and Thyroid Emergencies

Endocrine emergencies involving the adrenal and thyroid glands, while less common than diabetic crises, carry significant mortality if not promptly recognized and treated. The AGACNP must be adept at diagnosing and managing Adrenal Crisis, Thyroid Storm, and Myxedema Coma. These conditions often present with non-specific hemodynamic instability or altered mental status, making clinical suspicion paramount.

Adrenal Crisis (Acute Adrenal Insufficiency)

An adrenal crisis is a life-threatening state of profound cortisol and aldosterone deficiency. It most commonly occurs in patients with known chronic primary adrenal insufficiency (Addison's disease) who experience a physiologic stressor, such as infection, surgery, or trauma, without appropriate "stress dose" glucocorticoid coverage. Another critical etiology is the abrupt withdrawal of chronic exogenous steroid therapy, leading to secondary adrenal insufficiency due to HPA axis suppression. Rare but catastrophic causes include bilateral adrenal hemorrhage (often seen in the setting of severe sepsis, known as Waterhouse-Friderichsen syndrome, or anticoagulation therapy).

The hallmark clinical presentation is refractory distributive shock. The hypotension is typically unresponsive to aggressive fluid resuscitation and escalating doses of vasopressors because cortisol is required for the permissive action of catecholamines on vascular smooth muscle. Patients often present with severe weakness, profound fatigue, anorexia, nausea, vomiting, and non-specific, diffuse abdominal pain.

Laboratory findings are highly suggestive and stem from the lack of aldosterone (mineralocorticoid) and cortisol (glucocorticoid):

• Hyponatremia: Due to salt wasting (lack of aldosterone) and increased ADH secretion (due to volume depletion).
• Hyperkalemia: Due to impaired distal tubule potassium excretion (lack of aldosterone). Note: Hyperkalemia is typically seen only in primary adrenal insufficiency, not secondary, because the RAAS system remains intact in secondary disease.
• Hypoglycemia: Due to impaired gluconeogenesis (lack of cortisol).
• Non-anion gap metabolic acidosis.
• Eosinophilia on the CBC is a subtle but classic finding.

The diagnosis should be confirmed with a random serum cortisol and ACTH level drawn simultaneously; however, treatment must never be delayed pending laboratory results. A random cortisol level < 15 mcg/dL in a highly stressed, hypotensive patient is highly suggestive of insufficiency. An ACTH stimulation (cosyntropin) test can be performed later to confirm the diagnosis.

Management demands immediate intervention:

1. Glucocorticoid Replacement: Administer intravenous hydrocortisone 100 mg immediately, followed by 50 mg IV every 6 hours (or a continuous infusion of 200 mg/24 hours). Hydrocortisone is preferred because it possesses both glucocorticoid and sufficient mineralocorticoid activity at high doses.
2. Fluid Resuscitation: Aggressive volume expansion with 2-3 liters of normal saline (0.9% NaCl) or D5NS to correct volume depletion, hyponatremia, and hypoglycemia.
3. Identify and Treat Precipitants: Aggressively search for and treat the underlying cause, such as initiating broad-spectrum antibiotics for sepsis.

Once stabilized, hydrocortisone is tapered to a maintenance oral dose, and a daily mineralocorticoid (fludrocortisone) is added if primary adrenal insufficiency is confirmed.

Thyroid Emergencies: Thyroid Storm and Myxedema Coma

Thyroid emergencies represent the extreme, life-threatening manifestations of thyrotoxicosis and hypothyroidism, respectively. Both are triggered by acute stressors in patients with underlying, often poorly controlled, thyroid disease.

Thyroid Storm

Thyroid storm is an acute, fulminant exacerbation of hyperthyroidism (most commonly Graves' disease). It is typically precipitated by infection, surgery, trauma, iodine load (e.g., contrast media, amiodarone), or abrupt cessation of antithyroid medications.

The clinical picture is characterized by a hypermetabolic state and exaggerated sympathetic nervous system activity. Key features include:

• Extreme hyperpyrexia (temperatures often > 104°F / 40°C).
• Cardiovascular compromise: Marked tachycardia out of proportion to fever, atrial fibrillation with rapid ventricular response, and high-output heart failure progressing to cardiogenic shock.
• Central Nervous System dysfunction: Agitation, delirium, psychosis, and eventual coma.
• Gastrointestinal symptoms: Nausea, vomiting, diarrhea, and jaundice (a poor prognostic sign).

Diagnosis relies on the clinical presentation using tools like the Burch-Wartofsky Point Scale, as thyroid function tests (markedly suppressed TSH, elevated Free T3 and Free T4) do not distinguish between uncomplicated hyperthyroidism and thyroid storm.

Management requires a multi-modal blockade of the thyroid axis:

1. Beta-Blockade: To control adrenergic symptoms. Propranolol is preferred as it also inhibits peripheral conversion of T4 to T3. Esmolol is a rapidly titratable alternative for unstable patients.
2. Thionamides: To block new thyroid hormone synthesis. Propylthiouracil (PTU) or Methimazole is administered. PTU is often preferred in storm as it additionally blocks peripheral T4 to T3 conversion, though it carries a higher risk of hepatotoxicity.
3. Iodine Therapy: Administered at least 1 hour after the thionamide to block the release of preformed thyroid hormone (the Wolff-Chaikoff effect). Using iodine before a thionamide can provide substrate for further hormone synthesis. Potassium iodide solutions (Lugol's solution or SSKI) are used.
4. Glucocorticoids: High-dose IV hydrocortisone or dexamethasone blocks peripheral conversion of T4 to T3 and treats potential relative adrenal insufficiency.
5. Supportive Care: Aggressive cooling with acetaminophen and cooling blankets (avoid aspirin as it displaces thyroid hormone from binding proteins). Treat the underlying precipitant.

Myxedema Coma

Myxedema coma is the extreme, life-threatening manifestation of severe hypothyroidism. It is most often seen in elderly women during the winter months, precipitated by infection, cold exposure, sedatives, or non-adherence to levothyroxine therapy.

The hallmark is a profound hypometabolic state. The clinical presentation includes:

• Hypothermia: Often profound, without shivering.
• Hypoventilation: Leading to hypercapnia and respiratory acidosis, which is a major cause of mortality.
• Bradycardia and Hypotension: Decreased cardiac contractility and reduced systemic vascular resistance.
• Altered Mental Status: Ranging from lethargy and confusion to frank coma.
• Non-pitting edema (myxedema), particularly facial and periorbital.

Laboratory findings reflect severe primary hypothyroidism (markedly elevated TSH, very low Free T4) and associated metabolic derangements: hyponatremia (due to decreased free water clearance) and hypoglycemia.

Management is urgent and highly supportive:

1. Thyroid Hormone Replacement: Intravenous levothyroxine (T4) is the mainstay of therapy. IV liothyronine (T3) may be co-administered for a faster onset of action, especially if impaired peripheral conversion is suspected, but it carries a higher risk of provoking arrhythmias and ischemia in the elderly.
2. Glucocorticoids: Stress-dose IV hydrocortisone (e.g., 100 mg every 8 hours) is administered empirically until coexisting adrenal insufficiency (Schmidt syndrome) is ruled out by a random cortisol level. Administering thyroid hormone without ruling out adrenal insufficiency can precipitate an acute adrenal crisis by increasing metabolic demand and cortisol clearance.
3. Supportive Care: Mechanical ventilation for hypercapnic respiratory failure, passive rewarming for hypothermia (avoid active external rewarming, which can cause vasodilation and shock), and careful fluid management to correct hyponatremia and hypotension. Treat underlying infections aggressively.

Comparison of Endocrine Crises